Research on HIV - The Body

DO. SEE. HEAR. KNOW. Visit TheBody.com's 2008 World AIDS Day Center >>

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

Research on HIV

Show Archived (Historical) Articles

Engineered Killer T Cell Recognizes HIV-1's Lethal Molecular Disguises (November 10, 2008)
Implications for developing new treatments for AIDS.
From PENN Medicine
New Study May Help Explain How Untreated HIV Harms the Body (October 21, 2008)
In PLoS Medicine
Researchers Identify Novel Type of Antibody That Potently Inhibits HIV Infection (October 20, 2008)
From National Cancer Institute
Françoise Barré-Sinoussi and Luc Montagnier Win Nobel Prize for Discovery of HIV (October 6, 2008)
From Nobelprize.org
IAS Congratulates Dr. Françoise Barré-Sinoussi for Nobel Prize Award (October 6, 2008)
From International AIDS Society
Study Reveals Link Between Apobec3 Gene and Neutralizing Antibody Response to Retrovirus (September 4, 2008)
From National Institute of Allergy and Infectious Diseases
Blacks Are More Susceptible to HIV Than Whites Due to Genetic Quirk, Study Finds (July 17, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Study Examines Interaction Between HIV, Antibody That Helps Fight Infections (July 17, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Most HIV Cases Traced to Transmission of Single Virus, Study Finds (May 22, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Research Findings Open New Front in Fight Against AIDS Virus (April 28, 2008)
Human protein may offer novel target for blocking HIV infection.
From U.S. National Institutes of Health
HIV Might Spread More Quickly Within the Body Than Previously Thought (April 15, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
HIV May Reproduce Much Faster Than Previously Thought, Researchers Say (April 13, 2008)
In The Santa Fe New Mexican
Higher HCV RNA Levels Associated With Greater Early T-Cell Activation and CD4+ Cell Depletion Among Antiretroviral-Naive, HIV/HCV-Coinfected Patients (February 5, 2008)
From The Body PRO
HIV/Hepatitis C Coinfection Does Not Influence CD4+ Cell Recovery in Patients on Suppressive HAART (February 5, 2008)
Lars Peters, M.D., discusses his study, which counters long-established assumptions about the effect of HCV/HIV coinfection on immune recovery after patients commence antiretroviral therapy.
From The Body PRO
Mario Stevenson, Ph.D., Discusses Targets for a New Generation of HIV Antiretrovirals (February 3, 2008)
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
UCLA Researchers Find Cell Protein That Literally Nips HIV in the Bud (January 14, 2008)
From University of California-Los Angeles
Researchers Discover "Switch" Responsible for Turning Off the Immune System's Response Against HIV (September 30, 2007)
Potential treatment target needs further investigation before clinical testing.
From Massachusetts General Hospital
Palm Project Interview Series: Douglas Nixon (February 8, 2007)
From Treatment Action Group
An Interview With Dennis Burton: Structure-Function in HIV research (January/February 2007)
In IAVI Report, from International AIDS Vaccine Initiative
HIV/AIDS Treatment Should Target Gut Lining, Researchers Say (December 19, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
HIV Transmission Highest During Acute Infection and End-Stage Disease (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
Small Study Says HIV Now Replicating at a Slower Rate (October 3, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
U.S. Researchers Report Creation of HIV Strain That Infects Mice (March 4, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Scientists Discover a Key to How AIDS Virus Attacks the Body (February 24, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Basic Training: Session Recap From the 12th Conference on Retroviruses and Opportunistic Infections (January/February 2005)
Researchers review current knowledge on HIV virology, pathogenesis and antibodies.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Scientists Discover Key Genetic Factor in Determining HIV/AIDS Risk (January 6, 2005)
People with more copies of a gene that produces the chemokine CCL3L1 are less likely to have HIV.
From U.S. National Institute of Allergy and Infectious Diseases
Mortality Trends: Toward a New Definition of AIDS? (Winter 2004/2005)
An epidemiological review of the changing nature of HIV disease progression in the U.S.; includes a discussion of opportunistic infection trends.
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Highlighted Discussions From the Ninth Immune Restoration Think Tank (December 2004)
New developments in theories about HIV pathogenesis, T-cell activation and multi-drug resistant HIV.
In TAGline, from Treatment Action Group
HIV Replication Capacity and Treatment Decisions (November 2004)
What significance does the fitness of a person's virus have on HIV disease progression?.
To read PDF, click here
In Project Inform Perspective, from Project Inform
CD4 Gain Lower Among Older People Starting HAART Than Younger People (October 8, 2004)
Those over 50 were also much more likely to progress to AIDS after starting HAART, although paradoxically they were also more likely to reach an undetectable viral load.
From aidsmap.com
Fauci to Present Research Update at World AIDS Conference in Bangkok (July 15, 2004)
A news release summarizing Anthony Fauci, M.D.'s lecture on pathogenesis research at AIDS 2004.
From U.S. National Institute of Allergy and Infectious Diseases
Pathogenesis of HIV Disease: Current Concepts (PDF) (July 15, 2004)
A lecture by Anthony Fauci, M.D., given at the XV International AIDS Conference; available in RealPlayer video and Windows Media video.
From Henry J. Kaiser Family Foundation
Researchers Identify Mutations That Help HIV Avoid Immune Detection; Implications for Vaccine Development (June 2, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
COX-2 Inhibitors and CD4 -- Drug-Disease Interaction? (March/April 2004)
Research presented at CROI 2004 suggests that treatments for arthritis and chronic inflammatory conditions may have a deleterious effect on CD4 cells.
In Positively Aware, from Test Positive Aware Network
Filgrastim (Neupogen) May Stimulate HIV Disease Progression (March/April 2004)
Research from CROI 2004 suggests that this white blood cell stimulator may also increase viral replication.
In Positively Aware, from Test Positive Aware Network
HIV More Vulnerable to Vaccine During Acute Infection, Study Suggests (March 26, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Stable Partnership and Progression to AIDS or Death in HIV Infected Patients Receiving Highly Active Antiretroviral Therapy: Swiss HIV Cohort Study (January 3, 2004)
Abstract of a study finding that, from a health standpoint, relationships matter.
In British Medical Journal
Irish Scientist Discovers New Strain of AIDS Virus (July 9, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Researchers Further Quest to Infect Mice With HIV (July 2, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Online HIV Database Helps Researchers Analyze Virus (June 9, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV Pathogenesis Reports From the 10th Retrovirus Conference (April 2003)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Grant Awarded to HIV Research Software Developer (March 31, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV's Success Might Lie in Its Mutations (November 6, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Immune Response to HIV May Damage Lymph Nodes, Lower CD4 Counts in Some (October 10, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV Selectively Suppresses Anti-HIV Defense Cells (May 1, 2002)
From U.S. National Institute of Allergy and Infectious Diseases
Increasing Manganese Levels Inhibit HIV (April 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Arrested In Vivo: Viral Protein R (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
Invading the Immune Response: HIV Infection of HIV-Specific CD4 T Cells (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
Selected Highlights From Retrovirus: HIV Progression (February 28, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
P-Glycoprotein and HIV (January 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Accumulation of DC-SIGN+ CD40+ Dendritic Cells with Reduced CD80 and CD86 Expression in Lymphoid Tissue During Acute HIV-1 Infection (December 18, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
New Findings Explain T-Cell Loss in HIV Infection (December 10, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
HIV "Rides" into Cells on Membrane Rafts, NIAID Scientists Determine (November 19, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
Riddle Women: Reports of Progress Toward Understanding How Some People Appear to Fight Off HIV (November 2001)
In TAGline, from Treatment Action Group
Apparently Harmless Virus Associated with Reduced HIV Death (October 19, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
A Starchy Substance that Drains Cholesterol from Cell Membranes Can Completely Block HIV Transmission (August 22-29, 2001)
In Journal of the American Medical Association
NIAID Researchers Identify HIV-Induced Changes in B Cells (August 14, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
Genetic Variation May Affect AIDS Progression (Summer/Autumn 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Antibodies and HIV: New Evidence (Interview with Ruth Ruprecht, M.D., Ph.D.) (May 25, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
NIH Scientists Highlight Role of Macrophages in HIV Infection (January 1, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
Hitting HIV Early: A Swift Attack on the Virus Is a Sound Strategy (December 2000)
In Positive Living, from AIDS Project Los Angeles
Study May Shed Light on Acute Retroviral Syndrome (December 2000)
In Positive Living, from AIDS Project Los Angeles
T Cell's Internal "Housekeeping Service" Plays Role in HIV Infection (November 20, 2000)
From U.S. National Institute of Allergy and Infectious Diseases
New Finding on Immune Response to HIV Tat May Contribute to Vaccine, Treatment (September 22, 2000)
A study in monkeys has provided important information on how the immune response to HIV develops, why it is usually not sufficient, and how vaccine approaches might be tested more effectively in the future.
In AIDS Treatment News, from AIDS Treatment News
HIV Can Travel in B-Cells (Autumn 2000)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
B Cells May Help Maintain HIV Infection (August 29, 2000)
From U.S. National Institute of Allergy and Infectious Diseases
Striking the Balance: Brave New World of Human Gene Sequencing Finds Porous Policy Guidelines to its Liking (June 2000)
In TAGline, from Treatment Action Group
HIV Entry and Its Inhibition (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Measuring the Replicative Fitness of Recombinant HIV-1 Vectors Expressing Protease and Reverse Transcriptase Derived From Patient Viruses (January 31, 2000)
From Seattle Treatment Education Project
Primary Infection with HIV-1 with Reduced Drug Susceptibility Does Not Appear to Result from Point Source Transmission (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Molecular Traffic Signal Could Be New HIV Drug Target (December 8, 1999)
From U.S. National Institute of Allergy and Infectious Diseases
HIV in Genital Secretions: An Important Reservoir of Transcription-Competent Virus (August 1999)
In HIV Newsline, from San Francisco General Hospital
Report on Genetic Diversity Conference (June 30, 1999)
In HIV Genetic Diversity: Emerging Clinical Issues, from The Body PRO
Chemokines and HIV Coreceptors: Opening Doors to New Anti-HIV Strategies (May 25, 1999)
From U.S. National Institute of Allergy and Infectious Diseases
T-Cell Activation Predictive of Poor Survival in Advanced Disease (April 16, 1999)
From AIDS Treatment News
CD4 Nadir and Disease Progression (April 1999)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Viral and Immunologic Examination of HIV-I-Infected Persistently Seronegative Persons (February 1, 1999)
In The 6th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Scientists Report New Lead in the Regulation of HIV Coreceptor (October 8, 1998)
From U.S. National Institutes of Health
Reservoirs of HIV Infection (October 1998)
In HIV Newsline, from San Francisco General Hospital
New, More Virulent Strain of HIV Found (September 5, 1998)
In British Medical Journal
Pool of Latently Infected, "Resting" Cells Established Early in HIV Infection (July 20, 1998)
From U.S. National Institute of Allergy and Infectious Diseases
Crystal Structure of Key HIV Protein Reveals New Prevention, Treatment Targets (June 17, 1998)
From U.S. National Institute of Allergy and Infectious Diseases
Scientists Say Latently Infected Cells May Stoke the Fire of HIV Replication (May 26, 1998)
From U.S. National Institute of Allergy and Infectious Diseases
CD4 Increase Despite Protease Inhibitor "Failure" in Swiss Study (March 20, 1998)
In AIDS Treatment News, from AIDS Treatment News
Chemokine Receptors and HIV/SIV (February 2, 1998)
From Seattle Treatment Education Project
HIV Found in Lymph Tissue of Patients with "Undetectable" Viral Levels (December 1997)
In HIV Newsline, from San Francisco General Hospital
Infectious HIV Persists After Up to 2 1/2 Years of Triple Drug Therapy, Due to a Non-Decaying 3rd Compartment (December 1997)
From Treatment Action Group
More on How HIV Enters Cells (December 1997)
In HIV Newsline, from San Francisco General Hospital
HIV Persists and Can Replicate Despite Prolonged Combination Therapy (November 13, 1997)
From U.S. National Institute of Allergy and Infectious Diseases
HIV Subterfuge Revealed (October 29, 1997)
From U.S. National Institute of Allergy and Infectious Diseases
Chemokines: Implications for HIV (Summer 1997)
In STEP Perspective, from Seattle Treatment Education Project
The Clinical Significance of Surrogate Markers (June 1997)
In HIV Newsline, from San Francisco General Hospital

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.